To explore the possibility that CD44+/CD24– population bears cancer stem cell-like property, we examined the correlation between HER2 and CD44+/CD24– population by overexpressing or knocking down HER2 in different ovarian cancer cell lines. Here, ERBB2 is linked to ovarian carcinoma.